Lupin gets final USFDA nod for Mylan’s skin disease cream Industry-The Economic Times — February 3, 2017 comments off The approval is for multiple strengths of 0.025 per cent, 0.1 per cent and 0.5 per cent triamcinolone acetonide cream, said the company.
The approval is for multiple strengths of 0.025 per cent, 0.1 per cent and 0.5 per cent triamcinolone acetonide cream, said the company.